Skip to content

Frailty and the Elderly in Martinique

Frail Elderly Subjects Martinique: Adverse Outcome After Hospitalisation in Geriatric Department

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02871557
Acronym
SAFMACohort
Enrollment
287
Registered
2016-08-18
Start date
2012-01-31
Completion date
2015-06-30
Last updated
2016-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly People With Polypathology or Disabilities

Brief summary

This was a prospective multicenter cohort study of elderly people admitted to the acute care for elders in Martinique. They were followed up to 36 months. It aimed to study the adverse outcomes. In all, 287 subjects were included. They were 85+/-6 years, and mainly women (61%).

Detailed description

The SAFMA cohort was an ad hoc study formed into the recruitment of the acute care for elders in the geriatric department of Martinique university Hospitals. The inclusion of subjects ran from January 1st 2012 to June 30th 2012. To be eligible, patients had to be 75 or over and hospitalised for acute condition. Each patient was visited by a specialist in geriatrics familiar with the survey procedures. In the course of this interview, patients were informed about the study, prior to signing the consent form. If the clinical status and/or the cognitive status of the patient did not enable informed consent, the interviewer referred to the subject's representative. Follow-up was performed by visits and telephone interview till 36 months.

Interventions

None listed

Sponsors

CHU de Reims
CollaboratorOTHER
Société Martiniquaise de Gérontologie et Gériatrie
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
75 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age of 75 years or over * Admitted to acute care for elders * Consent to participate

Exclusion criteria

* Impossibility to perform the tests * Refusals to participate

Design outcomes

Primary

MeasureTime frame
Mortality6 weeks
Nursing home admission6 weeks

Secondary

MeasureTime frame
Mortality6 month
Nursing home admission6 month

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026